Gene Patenting

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 5/15/2013

The biggest concern of the biotechnology industry caused by the impending Supreme Court decision in the AMP v. Myriad Genetics case is the threat to existing patents having claims to isolated human DNA (and the DNA from other...more

Bernstein Shur Business and Commercial Litigation Newsletter #27

by Paul McDonald, Daniel J. Murphy | Bernstein Shur on 5/2/2013

We are pleased to present the 27th edition of the Bernstein Shur Business and Commercial Litigation Newsletter. This month, we highlight stories that will have an impact on business, commerce and litigation, including the...more

IP Buzz - April 2013

by Therese Finan, Meaghan Hemmings Kent, Jeffrey D. Knowles, Martin Saad, Steven Schwarz | Venable LLP on 5/1/2013

In this issue: - Federal Circuit: Speak Now or Forever Hold Your Appeal - The Federal Circuit Draws the Line on Permissible Changes to Design Patent Claims – Or Does It? - DMCA Safe Harbor Upheld for...more

Dispelling the Myriad Gene Patent Harmonization Myth

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 5/1/2013

In the wake of the Supreme Court oral arguments in the Myriad “gene patent” case, most commentators are predicting that the Court will uphold the patent-eligibility of non-naturally occurring DNA sequences (such as cDNA), but...more

Supreme Debate: Are Human Genes Patentable?

by Therese Finan | Venable LLP on 5/1/2013

On April 15, 2013, tackling an issue of significant importance to the biotechnology and health care industries, the U.S. Supreme Court heard oral arguments over whether human genes are patentable and more specifically,...more

Coelacanth Genome Sequence Determined

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/30/2013

The coelacanth, an aquatic animal described as a "living fossil" when discovered in 1938, was thought to have gone extinct during late Cretaceous period, ~70 million years ago. Only about 300 specimens of the African...more

Batting Practice with DNA Patents at the U.S. Supreme Court

by Heather Khassian, Karthika Perumal, Ph.D., Michael R. Samardzija, Ph.D. | Bracewell & Giuliani LLP on 4/17/2013

The Supreme Court heard oral arguments today in Association of Molecular Pathology vs. Myriad Genetics (Docket 12-398) regarding the patent eligibility of isolated DNA sequences. More specifically, they probed both parties in...more

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

by Marc Hearron, Matthew Kreeger, James J. Mullen, III | Morrison & Foerster LLP on 4/16/2013

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to decide the question, “Are human genes patentable?” The Court’s decision in...more

"Human Genes" and Patents

by Antoinette F. Konski | Foley & Lardner LLP on 4/15/2013

At 10:00 A.M. on April 15th, the U.S. Supreme Court will entertain oral arguments in the dispute now known as the human “gene patenting” case. The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398...more

A Primer on Claim Construction -- Comments on Dr. Mason's Response

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 4/12/2013

Yesterday, we posted a response from Dr. Chris Mason of Cornell University to a recent Patent Docs post and an article posted by Dr. Chris Holman on Holman's Biotech IP Blog. Dr. Mason co-authored an article in the current...more

Dr. Chris Mason Responds to Blog Posts on Genome Medicine Article -- Updated

by McDonnell Boehnen Hulbert & Berghoff LLP on 4/11/2013

[Ed. Patent Docs recently reported on an article in the current issue of Genome Medicine which contends that due to the non-specificity of sequence uniqueness across the genome and the broad scope of claims to nucleotide...more

Revisiting Genome Medicine Article on "Pervasive Sequence Patents" That "Cover the Entire Human Genome"

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 4/9/2013

Last week, we reported on an article in the current issue of Genome Medicine which contends that due to the non-specificity of sequence uniqueness across the genome and the broad scope of claims to nucleotide sequences, the...more

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

by Lawline.com on 4/8/2013

We have all heard the popular adage: "the whole is greater than the sum of the parts." Can we ever say that the parts, when divided, are greater than their assembled whole? In relation to the issue of genetic patentability,...more

Briefing the Supreme Court in Myriad

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 3/29/2013

March 15, 2013 was a big deadline for patent applicants seeking to secure first-to-invent filing dates for U.S. patent applications, but April 15 will be a big day for the biotechnology industry, when the Supreme Court hears...more

Australian Federal Court Upholds Myriad’s Gene Patent

by James J. Mullen, III, Mary Prendergast | Morrison & Foerster LLP on 2/19/2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld Myriad Genetics’ patent on methods for screening for cancer-predisposing...more

Myriad Posts Gene Patenting Victory in Australia

by Antoinette F. Konski | Foley & Lardner LLP on 2/19/2013

In a companion case to the “gene patenting” dispute presently before the U.S. Supreme Court, Myriad Genetics, Inc. successfully defended the patent-eligibility of “gene patents” in Australia. In Cancer Voices et al. v. Myriad...more

News from Abroad: Federal Court of Australia Affirms Patentability of Isolated Nucleic Acids

by McDonnell Boehnen Hulbert & Berghoff LLP on 2/18/2013

On Friday, the Federal Court of Australia handed down its decision in the case of Cancer Voices Australia & Anor v Myriad Genetics Inc & Ors. The presiding judge, Justice Nicholas, identified the issue in the case as one "of...more

News from Abroad: Australian Federal Court Upholds Myriad's BRCA1 Gene Patents

by McDonnell Boehnen Hulbert & Berghoff LLP on 2/18/2013

In a significant win for Myriad, and their licensee Genetic Technologies Ltd, the Australian Federal Court on Friday upheld Myriad's method patents used in cancer screening for mutations in the BRCA1 gene. This decision will...more

Amici Urge Reversal of "Gene Patenting" Decision

by Antoinette F. Konski | Foley & Lardner LLP on 11/29/2012

On November 30th, 2012, the U.S. Supreme Court will conference and consider whether to review the patent-eligibility of isolated DNA sequences. Our prior post of September 25, 2012 addressed Petitioners’ brief and request for...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

Bernstein Shur Business and Commercial Litigation Newsletter #27

IP Buzz - April 2013

Dispelling the Myriad Gene Patent Harmonization Myth

Supreme Debate: Are Human Genes Patentable?

Coelacanth Genome Sequence Determined

Batting Practice with DNA Patents at the U.S. Supreme Court

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

"Human Genes" and Patents

A Primer on Claim Construction -- Comments on Dr. Mason's Response

Dr. Chris Mason Responds to Blog Posts on Genome Medicine Article -- Updated

Revisiting Genome Medicine Article on "Pervasive Sequence Patents" That "Cover the Entire Human Genome"

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Briefing the Supreme Court in Myriad

Australian Federal Court Upholds Myriad’s Gene Patent

Myriad Posts Gene Patenting Victory in Australia

News from Abroad: Federal Court of Australia Affirms Patentability of Isolated Nucleic Acids

News from Abroad: Australian Federal Court Upholds Myriad's BRCA1 Gene Patents

Amici Urge Reversal of "Gene Patenting" Decision

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Expand Your Reach